A detailed history of Point72 (Difc) LTD transactions in Nkarta, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 3,896 shares of NKTX stock, worth $7,285. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,896
Holding current value
$7,285
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$1.67 - $2.37 $6,506 - $9,233
3,896 New
3,896 $8.07 Million
Q3 2024

Nov 14, 2024

BUY
$4.52 - $8.0 $20,113 - $35,600
4,450 New
4,450 $20.1 Million

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $91M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Point72 (Difc) LTD Portfolio

Follow Point72 (Difc) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.